Hygea Medical Technology is a oncology-focused biopharma company.
Hygea Medical Technology is a oncology-focused biopharma company. Hygea’s solutions cater to cancer therapies targeting diseases in the lung, liver, breast, and kidney. Hygea will continue to develop its micro-invasive and Cryo-HITTM technology.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 15, 2023 | Series D | ¥100M | 1 | — | — | Detail |
Dec 6, 2019 | Series B | $28M | 2 | Jianxing Medical Fund | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Jianxing Medical Fund | Yes | Series B |
Gaorong Capital | — | Series D |
Kunying Capital | — | Series B |